Under construction – not a live service
Sign in
Taking people in FranceNo phase

Neurofeedback-EEG Rehabilitation Protocol on Motor Recovery in the Subacute Phase Post-stroke (CUSTOM-NF-STROKE)

Key facts

Where
Toulouse, FranceSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 99 years old?

Source: NCT06212219, who can take part

Where in France

  • CHU de ToulouseToulouse, FranceTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
University Hospital, Toulouse
Trial code
NCT06212219
Record updated
29 May 2026
Original description
Neurofeedback (NF) is a procedure for providing direct sensory feedback (in the form of visual, auditory or tactile stimulation) to a patient about their brain activity when performing a cognitive or motor task. This NF aims to allow the patient to become aware of this brain activity and thus learn to modulate it voluntarily in order to improve the performance obtained on the task.Read full original descriptionShow less

Impact of Personalization of a Neurofeedback-EEG Rehabilitation Protocol on Motor Recovery in the Subacute Phase Post-stroke (CUSTOM-NF-STROKE)

Neurofeedback (NF) is a procedure for providing direct sensory feedback (in the form of visual, auditory or tactile stimulation) to a patient about their brain activity when performing a cognitive or motor task. This NF aims to allow the patient to become aware of this brain activity and thus learn to modulate it voluntarily in order to improve the performance obtained on the task.

The aim of the study is to compare a "standard NF" procedure to a "personalized NF" procedure designed to optimize the level of patient acceptability based on the results obtained through these questionnaires.

Inclusion: Man, woman, over 18 years old; Motor deficit of the upper limb type of hemiplegia, secondary to a hemorrhagic or ischemic stroke authenticated by brain imaging (MRI or CT); Post-stroke patients in the subacute phase, between 15 days and 6 months after the stroke; Correct or corrected vision allowing reading at a distance of 0 to 2m; Ability to maintain a seated position for 1 hour; Patient affiliated to a social security scheme or beneficiary of such a scheme; Informed patient having signed consent.

Exclusion: Factors hindering EEG acquisition (scalp pathology, abnormal cervico-cephalic movements, cranial metal implants); Phasic disorder limiting comprehension corresponding to a Boston Diagnostic Aphasia Examination (BDAE) score < 4; Attentional disorder not allowing sufficient attention to be maintained for 1 hour; History of known stroke with motor sequelae; Unstabilized epilepsy; Minors (age < 18 years); Known peripheral neurological pathology affecting the paretic upper limb; Other known central neurological pathology; Refusal to participate in the study; Protected patient: adult under guardianship, curatorship or other legal protection, deprived of liberty by judicial or administrative decision; Pregnant, parturient, or breastfeeding patient.

ClinicalTrials.gov NCT06212219